Novartis Patient Support®
  • Support 1-844-638-7222
Novartis Patient Support
Registered User Sign-In
For support, call 1-844-638-7222
Forgot password?
New user?
Novartis Patient Support

Novartis Patient Support

Request an Account
Facility/Practice not found? Request a new facility
Request a New Facility
Cancel new facility

Use this option if you did not find your facility/practice listed above.

Admin users will have the ability to add, edit, and delete other user accounts for this facility/practice.
Please provide information about the user who will act as the Administrator for this facility/practice
Novartis Patient Support

Novartis Patient Support

Request an Account

Thank you for your submission. We’ll evaluate your request and respond as soon as possible.

Novartis Patient Support
Forgot Password
Enter your email address to receive a reset password link
Cancel

If you need assistance with a password reset, please contact 844-638-7222

A notification has been sent to your email address with instructions on how to reset your password.

If you do not receive the email in a few minutes or need assistance with a password reset, please contact 844-638-7222

Novartis Patient Support
Reset Password
Enter your access code to complete your password change
xxx-xxx-

If you need assistance with a password reset, please contact Customer Support

Novartis Patient Support
Complete Invite
Enter your access code to complete your registration
xxx-xxx-

If you need assistance with a password reset, please contact Customer Support

Novartis Patient Support
Prescriber Certification
For support, call (844) 638-7222

You have a patient interested in enrolling in Novartis Patient Support. To complete the process and provide your certification, please enter your information below.

Novartis Patient Support
Enter Your Access Code
For support, call (844) 638-7222

Welcome,

To receive your access code via text message at the mobile number ending in , click the button below. If you do not want to receive a text message or have not provided a mobile number, please call (844) 638-7222 to request your access code.

Please call (844) 638-7222 to request your access code.

Case ID:

Novartis Patient Support
Patient Consent Sign In
For support, call (844) 638-7222

Thank you for your interest in enrolling in Novartis Patient Support. To complete the process and provide your consent, please enter your information below.

Novartis Patient Support
Enter Your Access Code
For support, call (844) 638-7222

Welcome,

To receive your access code via text message at the mobile number ending in , click the button below. If you do not want to receive a text message or have not provided a mobile number, please call (844) 638-7222 to request your access code.

Please call (844) 638-7222 to request your access code.

Case ID:

Novartis Patient Support
Sign In Error
Unable to authorize this user account

If you need assistance, please contact Customer Support

The billing and coding information provided by Novartis is gathered from various sources and is subject to change without notice. It is not intended to guarantee, increase, or maximize reimbursement by any payer. It is the provider's responsibility to report the codes that accurately describe the products and services furnished to individual patients. Coverage and reimbursement may vary significantly by payer, plan, patient, and setting of care. We recommend that providers consult third-party payers for specific information regarding their coding, coverage, and payment policies and rates. Laws and regulations regarding reimbursement change frequently and providers are solely responsible for all decisions related to coding and billing, including determining if, and under what circumstances, it is appropriate to seek reimbursement for products and services and obtaining preauthorization, if necessary. Novartis makes no representation or warranty regarding this information or its completeness or accuracy and will bear no responsibility for the results or consequences of the use of this information. You should reference the Current Procedural Terminology (CPT), International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM), and Healthcare Common Procedure Coding System (HCPCS) manuals for the most detailed and up-to-date information. Current Procedural Terminology (CPT® ) is a copyright and registered trademark of the American Medical Association (AMA).
Novartis Patient Support® is a trademark of Novartis AG
LUTATHERA® (lutetium Lu 177 dotatate) is a trademark of Novartis AG and/or its affiliates.
NETSPOT® (kit for the preparation of gallium Ga 68 dotatate injection) is a trademark of Novartis AG and/or its affiliates.
PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) is a trademark of Novartis AG and/or its affiliates.
LOCAMETZ® (kit for the preparation of gallium Ga 68 gozetotide injection) is a trademark of Novartis AG and/or its affiliates.
Use of website is governed by the Terms of Use and Privacy Policy. Copyright © 2024 Novartis Pharmaceuticals Corporation. All rights reserved.
This website is intended for use by US health care professionals only.
Privacy Policy
264011 | 2/23

Not Found

You have been logged in, however it does not appear that you have access to anything on this site

Please contact your system administrator to verify your permissions

Logout
The billing and coding information provided by Novartis is gathered from various sources and is subject to change without notice. It is not intended to guarantee, increase, or maximize reimbursement by any payer. It is the provider's responsibility to report the codes that accurately describe the products and services furnished to individual patients. Coverage and reimbursement may vary significantly by payer, plan, patient, and setting of care. We recommend that providers consult third-party payers for specific information regarding their coding, coverage, and payment policies and rates. Laws and regulations regarding reimbursement change frequently and providers are solely responsible for all decisions related to coding and billing, including determining if, and under what circumstances, it is appropriate to seek reimbursement for products and services and obtaining preauthorization, if necessary. Novartis makes no representation or warranty regarding this information or its completeness or accuracy and will bear no responsibility for the results or consequences of the use of this information. You should reference the Current Procedural Terminology (CPT), International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM), and Healthcare Common Procedure Coding System (HCPCS) manuals for the most detailed and up-to-date information. Current Procedural Terminology (CPT® ) is a copyright and registered trademark of the American Medical Association (AMA).
Novartis Patient Support® is a trademark of Novartis AG
LUTATHERA® (lutetium Lu 177 dotatate) is a trademark of Novartis AG and/or its affiliates.
NETSPOT® (kit for the preparation of gallium Ga 68 dotatate injection) is a trademark of Novartis AG and/or its affiliates.
PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) is a trademark of Novartis AG and/or its affiliates.
LOCAMETZ® (kit for the preparation of gallium Ga 68 gozetotide injection) is a trademark of Novartis AG and/or its affiliates.
Use of website is governed by the Terms of Use and Privacy Policy. Copyright © 2024 Novartis Pharmaceuticals Corporation. All rights reserved.
This website is intended for use by US health care professionals only.
Privacy Policy
264011 | 2/23